HIGHLIGHTS
- who: Ting Xu from the Department of Blood Transfusion, Southwest Hospital, Third Military Medical University (Army Medical University), of Tumor Immunopathology, Ministry of Education of China, China have published the research: Carboxypeptidase N2 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma, in the Journal: (JOURNAL)
- what: The use of clinical specimens for research purposes has been approved by the Research Ethics Committee of Shanghai Outdo Biotech Co., Ltd The study provided ample evidence for the importance of CPN2 in carcinogenic properties and potential prognostic biomarker for LUAD. Integrating the results of GSEA and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.